Five IPOs raised $565 million this past week. The deals average +30% from the offer price, while none broke issue and most priced above the midpoint of the range.
...read more
Biotie Therapies, which is developing a therapy to extend the efficacy of levodopa for Parkinson's disease, raised $56 million by offering 3.8 million ADSs at $14.888. Biotie Therapies plans to list on the NASDAQ under the symbol BITI. Biotie Therapies...read more
Cynapsus Therapeutics, which is developing a sublingual formulation of an approved therapy for Parkinson's disease, announced terms for its IPO on Tuesday. Cynapsus is currently listed on the Toronto Stock Exchange under the symbol CTH with a basic market...read more
Fast casual chicken wing chain Wingstop leads the six deals on this week's IPO calendar. After three weeks without a biotech, we'll see one with a proposed valuation of $1.4 billion....read more
US IPO Weekly Recap: Wingstop unstoppable while massive biotech pops 99% then drops
Five IPOs raised $565 million this past week. The deals average +30% from the offer price, while none broke issue and most priced above the midpoint of the range. ...read more
Biotie Therapies prices IPO at $14.888
Biotie Therapies, which is developing a therapy to extend the efficacy of levodopa for Parkinson's disease, raised $56 million by offering 3.8 million ADSs at $14.888. Biotie Therapies plans to list on the NASDAQ under the symbol BITI. Biotie Therapies...read more
Under-the-tongue Parkinson's therapy: Cynapsus Therapeutics sets terms for $64 million US IPO
Cynapsus Therapeutics, which is developing a sublingual formulation of an approved therapy for Parkinson's disease, announced terms for its IPO on Tuesday. Cynapsus is currently listed on the Toronto Stock Exchange under the symbol CTH with a basic market...read more
Week ahead: 6 IPOs planned for the week of June 8
Fast casual chicken wing chain Wingstop leads the six deals on this week's IPO calendar. After three weeks without a biotech, we'll see one with a proposed valuation of $1.4 billion....read more